Novavax Wins Fast-Track Designation for Flu Vaccine

Shares of Novavax (NASDAQ: NVAX) were up more than 10% Wednesday after the company announced that the U.S. Food and Drug Administration (FDA) granted its next-generation flu vaccine candidate, NanoFlu, fast-track designation for use by adults 65 and over.